Co-stimulatory molecule clusters correlate with survival, immune infiltration, and tumor mutation burden in non-small cell lung cancer

Co-stimulatory molecule clusters correlate with survival, immune infiltration, and tumor mutation burden in non-small cell lung cancer

We aimed to identify co-stimulatory molecule clusters and explore their associations with immune infiltration and tumor mutation burden (TMB) in non-small cell lung cancer (NSCLC), using a systematic analysis based on RNA-seq and mutation data in TCGA database. Twelve immune-related prognostic co-st...

Full description

Bibliographic Details
Main Authors:	Chunxiao Wu, Qiquan Yu, Weizhen Shou, Kun Zhang, Yang Li, Wentao Guo, Qi Bao
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2022-12-01
Series:	All Life
Subjects:	non-small cell lung cancer co-stimulatory molecules immune molecular clusters tumor mutation burden
Online Access:	http://dx.doi.org/10.1080/26895293.2022.2085814

Similar Items

The Role of Co-Stimulatory Molecules in Chagas Disease
by: Bruna F. Pinto, et al.
Published: (2018-11-01)

Adhesion and Co-stimulatory Molecules in the Pathogenesis of Hepatic and Intestinal Schistosomiasis Mansoni
by: Werner Jacobs, et al.
Published: (1998-07-01)

Aberrant Expressions of Co-stimulatory and Co-inhibitory Molecules in Autoimmune Diseases
by: Weiwei He, et al.
Published: (2019-02-01)

Thalidomide with blockade of co-stimulatory molecules prolongs the survival of alloantigen-primed mice with cardiac allografts
by: Maoshu Zhu, et al.
Published: (2020-04-01)

T cell co-stimulatory and co-inhibitory pathways in atopic dermatitis
by: Chunjiao Zheng, et al.
Published: (2023-03-01)

Dendritic cell and co-stimulatory molecule targeted therapy for autoimmune diseases: a review of the newly implemented strategies
by: Mazen El Jamal, et al.
Published: (2024-04-01)

How Co-Stimulatory/Inhibitory Molecules Vary Across Immune Cell Subtypes in the Severity of Systemic Lupus Erythematosus Compared to Controls
by: Kuang-Hui Yu, et al.
Published: (2024-10-01)

A Phase I Trial of Pox PSA vaccines (PROSTVAC<sup>®</sup>-VF) with B7-1, ICAM-1, and LFA-3 co-stimulatory molecules (TRICOM™) in Patients with Prostate Cancer
by: Lattime E, et al.
Published: (2006-01-01)

Inducible co-stimulatory molecule (ICOS) alleviates paclitaxel-induced neuropathic pain via an IL-10-mediated mechanism in female mice
by: Ishwarya Sankaranarayanan, et al.
Published: (2023-02-01)

Epigenetic modifications and metabolic gene mutations drive resistance evolution in response to stimulatory antibiotics
by: Hui Lin, et al.
Published: (2025-01-01)

Anti-PD-L1-Based Bispecific Antibodies Targeting Co-Inhibitory and Co-Stimulatory Molecules for Cancer Immunotherapy
by: Qiaohong Geng, et al.
Published: (2024-01-01)

Hyper-fractionated radiotherapy as a bridging strategy to enhance CAR-T efficacy by regulating T-cell co-stimulatory molecules in relapsed/refractory diffuse large B-cell lymphoma
by: Jing Ruan, et al.
Published: (2024-12-01)

The Role of Co-Signaling Molecules in Psoriasis and Their Implications for Targeted Treatment
by: Suqing Liu, et al.
Published: (2021-07-01)

Prognostic and immunological characterization of diffuse large B-cell lymphoma evaluated by co-stimulatory molecular-related features
by: Lixia Sheng, et al.
Published: (2023-09-01)

Mechanism of osteoclast stimulatory transmembrane protein promoting silicosis fibrosis by inducing ferroptosis
by: Jing WU, et al.
Published: (2023-11-01)

Impaired monocyte‐derived dendritic cell phenotype in prostate cancer patients: A phenotypic comparison with healthy donors
by: Parisa Bakhshi, et al.
Published: (2024-02-01)

Investigation of the association between the genetic polymorphisms of the co-stimulatory system and systemic lupus erythematosus
by: Ding-Ping Chen, et al.
Published: (2022-09-01)

A modified assay for measuring thymocyte co-stimulatory activity
by: Sergio R. Dalmau, et al.
Published: (1993-09-01)

Corrigendum: Investigation of the association between the genetic polymorphisms of co-stimulatory system and systemic lupus erythematosus
by: Ding-Ping Chen, et al.
Published: (2023-01-01)

Characteristics and predictors of auto-stimulatory behavior in children with autism
by: Ana Lukić, et al.
Published: (2023-01-01)

T Cell Co-Stimulation: Inhibition of Immunosuppression?
by: Karl-Gösta Sundqvist
Published: (2018-05-01)

BLM mutation is associated with increased tumor mutation burden and improved survival after immunotherapy across multiple cancers
by: Huiping Shi, et al.
Published: (2024-01-01)

CD45RA+CCR7− CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumab
by: Andre Kunert, et al.
Published: (2019-06-01)

Development and evaluation of a herbal formulation with anti-pathogenic activities and probiotics stimulatory effects
by: Qian ZHOU, et al.
Published: (2016-05-01)

Targeting radiation‐induced upstream stimulatory factor‐1 by histone deacetylase inhibitors to reverse radioresistance in prostate cancer
by: Seema Gupta, et al.
Published: (2022-12-01)

The Stimulatory Effects of Medicinal Plants on β2-adrenoceptors of Tracheal Smooth Muscle
by: Farzaneh Shakeri, et al.
Published: (2019-02-01)

Significance of tumor mutation burden and immune infiltration in thymic epithelial tumors
by: Zi‐Ming Wang, et al.
Published: (2021-07-01)

Burden of tumor mutations, neoepitopes, and other variants are weak predictors of cancer immunotherapy response and overall survival
by: Mary A. Wood, et al.
Published: (2020-03-01)

Integrated Analysis of Tumor Mutation Burden and Immune Infiltrates in Hepatocellular Carcinoma
by: Yulan Zhao, et al.
Published: (2022-08-01)

Substratum interactions determine immune response to allogeneic transplants of endothelial cells
by: Elise C. Wilcox, et al.
Published: (2022-08-01)

Systemic Immune Dysregulation in Early Breast Cancer Is Associated With Decreased Plasma Levels of Both Soluble Co-Inhibitory and Co-Stimulatory Immune Checkpoint Molecules
by: Bernardo L. Rapoport, et al.
Published: (2022-05-01)

Identification of a novel GNAS mutation in a case of pseudohypoparathyroidism type 1A with normocalcemia
by: Xiao-dan Long, et al.
Published: (2018-07-01)

The prognostic value of tumor mutation burden (TMB) and its relationship with immune infiltration in breast cancer patients
by: Shengjin Cui, et al.
Published: (2023-02-01)

Next-Generation Sequencing Reveals High Uncommon EGFR Mutations and Tumour Mutation Burden in a Subgroup of Lung Cancer Patients
by: Gang Guo, et al.
Published: (2021-04-01)

Immunogenicity and Protective Efficacy of T-Cell Epitopes Derived From Potential Th1 Stimulatory Proteins of Leishmania (Leishmania) donovani
by: Sumit Joshi, et al.
Published: (2019-02-01)

The inhibitory and stimulatory behavior for some of chemical compounds and watery extract of black tea and Arabian coffee on the swarming phenomenon of clinical isolates of Proteus mirabilis.
by: Bahaa Abdullah Laftaah
Published: (2012-10-01)

Exploration of the association between the single-nucleotide polymorphism of co-stimulatory system and rheumatoid arthritis
by: Ding-Ping Chen, et al.
Published: (2023-06-01)

Correlations Between Tumor Mutation Burden and Immunocyte Infiltration and Their Prognostic Value in Colon Cancer
by: Zhangjian Zhou, et al.
Published: (2021-02-01)

Correlation of tumor mutational burden with prognosis and immune infiltration in lung adenocarcinoma
by: Lin Li, et al.
Published: (2023-03-01)

Identification and validation of a tumor mutation burden-related signature combined with immune microenvironment infiltration in adrenocortical carcinoma
by: Yong Luo, et al.
Published: (2022-05-01)